Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes Synthesis
A new one-pot approach of conjugated tetraenes from 1,3-butadiene and two substituted acetylenes catalyzed by a zero-valent ruthenium complex. Credit: Department of Applied Chemistry, Graduate School of Engineering, Tokyo University of Agriculture and Technology
Conjugated tetraenes are important key substructures in electronic materials, natural products and pharmaceutical molecules. However, they are difficult to synthesize. They are conventionally prepared by repetitions of the stoichiometric reactions using phosphorus reagents and subsequent reduction and partial oxidation. For making one C=C double bond, one needs to conduct 3 step reactions by this procedure. Each process produces wastes of phosphorus oxides and metal compounds such as lithium, aluminum and manganese. Removal of organic solvents and purification processes are also required. An alternative catalytic approach is the cross-coupling reaction catalyzed by a Pd complex but this method needs to prepare an activated alkenyl or dienyl metal species in advance.
TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. This is the most straightforward synthetic method ever reported. This new method has been published in the ACS journal, Organometallics.
"The Ru catalyst precisely distinguishes butadiene and substituted acetylene molecules and new carbon-carbon bonds are formed among a butadiene with two acetylenes just by migration of the terminal hydrogen atoms in butadiene. Interestingly, this catalysis proceeds regio- and stereoselectively and no wastes are produced from the reaction" said Masafumi Hirano, a TUAT professor of chemistry and principal of the study.
The current scope is, however, limited to internal alkynes (1,2-disubstituted acetylenes), and the present reaction entails internal side groups in the conjugated tetraenes. However, facile detachment of some side groups is possible to give the linear conjugated polyenes and this protocol will be disclosed in the 98th annual meeting of the Chemical Society of Japan.
Instead of 1,3-butadiene, 1-substituted 1,3-butadienes such as 1,3-pentadiene or 2,4-pentadienoate are also possible to use for the reaction but conjugated trienes are produced in this case.
The mechanism is revealed by the isotopic labeling experiments and the stoichiometric reactions by use the 1,3-butadiene complex of ruthenium. These studies demonstrate this reaction to be a formal syn addition of the terminal C-H bond in butadiene to acetyelene.
Conjugated tetraenes are important key substructures in organic-electronic materials, biologically active natural products such as vitamins, and anti-mycotic drugs and this new method may contribute to the preparations of them. "The ultimate goal is versatile synthesis of targeted conjugated polyene molecules and to supply conjugated polyene substructures by this inexpensive method", said Masafumi. That could lead to facile and inexpensive synthesis of molecules for electronic materials and anti-mycotic drugs.
Masafumi and colleagues set out to prepare the targeted molecules containing conjugated tetraene substructures.
This article has been republished from materials provided by American Chemical Society. Note: material may have been edited for length and content. For further information, please contact the cited source.
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
Tiny Particles Carry Tumor Shrinking Drugs into the BrainNews
MIT researchers have now devised a new drug-delivering nanoparticle that could offer a better way to treat glioblastoma. The particles, which carry two different drugs, are designed so that they can easily cross the blood-brain barrier and bind directly to tumor cells.READ MORE
Rapamycin Lotion Reduces Facial Tumors Caused by Tuberous SclerosisNews
Addressing a critical issue for people with a genetic disorder called tuberous sclerosis complex (TSC), doctors reported that a skin cream containing rapamycin significantly reduced the disfiguring facial tumors affecting more than 90 percent of people with the condition.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018